Prof. Dr. ALİ KOŞAR

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 63

1. Is mean platelet volume related to disease activity in systemic lupus erythematosus?

UZKESER H., Keskin H., Haliloglu S., ÇAYIR Y., Karaaslan Y., KOŞAR A., et al.

International Journal of Clinical Practice , cilt.75, sa.11, 2021 (SCI-Expanded)

2. The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients

Yalçın K. S., Kasapoğlu B., Alanlı R., Küçükay M. B., Koşar A.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.31, sa.8, ss.558-561, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

3. The frequency of raynaud’s phenomenon in patients with methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia

YALÇIN K. S., KOŞAR A.

Turkish Journal of Medical Sciences , cilt.49, sa.5, ss.1444-1449, 2019 (SCI-Expanded)

4. MTHFR 677C/T and 1298A/C mutations and non-alcoholic fatty liver disease

KASAPOĞLU B., Turkay C., YALÇIN K. S., KOŞAR A., Bozkurt A.

Clinical Medicine, Journal of the Royal College of Physicians of London , cilt.15, sa.3, ss.248-251, 2015 (SCI-Expanded)

5. Is mean platelet volume a new activity criteria in Behçet's disease?

UZKESER H., Haliloglu S., Cayir Y., Bilen N., Karaaslan Y., KOŞAR A., et al.

Blood Coagulation and Fibrinolysis , cilt.26, sa.7, ss.836-839, 2015 (SCI-Expanded)

6. Neutrophil-lymphocyte ratio (NLR) could be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis(NASH)

Yilmaz H., YALÇIN K. S., Namuslu M., Celik H. T., Sozen M., Inan O., et al.

Annals of Clinical and Laboratory Science , cilt.45, sa.3, ss.278-286, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Mean platelet volume in patients with fibromyalgia Mittleres Thrombozytenvolumen bei Patienten mit Fibromyalgie

Haliloğlu S., Carlioglu A., Sahiner E., Karaaslan Y., KOŞAR A.

Zeitschrift fur Rheumatologie , cilt.73, sa.8, ss.742-745, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

8. Fibromyalgia in patients with other rheumatic diseases: Prevalence and relationship with disease activity

Haliloglu S., Carlioglu A., Akdeniz D., Karaaslan Y., KOŞAR A.

Rheumatology International , cilt.34, sa.9, ss.1275-1280, 2014 (SCI-Expanded)

9. Human Immunodeficiency Virus (HIV)-Negative and Human Herpes Virus-8 (HHV-8)-Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature

Karataş S. G., Bayrak R., Balçk Ö. Ş., Yalçn K. S., Atici E., Akyildiz Ü., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.1, ss.67-71, 2013 (SCI-Expanded)

10. Thrombopoietin and mean platelet volume in patients with ischemic stroke

Balcik Ö. S., Bilen S., Ulusoy E. K., Akdeniz D., Uysal S., Ikizek M., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.19, sa.1, ss.92-95, 2013 (SCI-Expanded)

11. A placebo-controlled, randomized, double-blinded, cross-over phase-i clinical study indicating the safety of topical ankaferd hemostat in healthy volunteers topikal ankaferd hemostat'i{dotless}n güvenilirli{currency sign}ini yansi{dotless}tan saǧli{dotless}kli{dotless} gönüllülerde yapi{dotless}lmi{dotless}fl plasebo kontrollü, randomize, çift kör, çapraz geçiflli faz-i klinik çali{dotless}flma

Balcik O. S., Koroglu M., Cipil H., Kaftan O., Maral S., Gurel A., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.22, sa.4, ss.267-274, 2012 (SCI-Expanded)

12. Relationship between some clinical situations, autoantibodies, and pseudothrombocytopenia

Isik A., Balcik O. S., Akdeniz D., Cipil H., Uysal S., KOŞAR A.

Clinical and Applied Thrombosis/Hemostasis , cilt.18, sa.6, ss.645-649, 2012 (SCI-Expanded)

13. Heparin platelet factor 4 antibody positivity in pseudothrombocytopenia

Balcik O. S., Akdeniz D., Cipil H., Uysal S., Isik A., KOŞAR A.

Clinical and Applied Thrombosis/Hemostasis , cilt.18, sa.1, ss.92-95, 2012 (SCI-Expanded)

14. Serum thrombopoietin levels in patients with non-alcoholic fatty liver disease

Balcik O. S., Akdeniz D., Cipil H., Ikizek M., Uysal S., KOŞAR A., et al.

Saudi Medical Journal , cilt.33, sa.1, ss.30-33, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Evaluation of a haemostatic agent in rabbits

Turhan N., Bilgili H., Captug O., Kurt M., Shorbagi A., Beyazit Y., et al.

African Journal of Traditional, Complementary and Alternative Medicines , cilt.8, sa.1, ss.61-65, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myeloma

Balcik O. S., Albayrak M., Uyar M. E., Dagdas S., Yokus O., Ceran F., et al.

Blood Coagulation and Fibrinolysis , cilt.22, sa.4, ss.260-263, 2011 (SCI-Expanded)

17. Treatment of adverse perinatal outcome in inherited thrombophilias: A clinical study

KOŞAR A., KASAPOĞLU B., Kalyoncu S., Turan H., Balcik O. S., Gümüs E. I.

Blood Coagulation and Fibrinolysis , cilt.22, sa.1, ss.14-18, 2011 (SCI-Expanded)

18. Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients

Kaftan O., KASAPOĞLU B., Koroglu M., KOŞAR A., Yalcin S.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.4, ss.332-335, 2011 (SCI-Expanded)

19. Portal vein thrombosis secondary to Klebsiella oxytoca bacteriemia Klebsiella oxytoca bakteriyemisine sekonder portal ven trombozu

Uz E., Özlem A., Balçik Ö. Ş., Kanbay M., Işik A., Uz B., et al.

Turkish Journal of Hematology , cilt.27, sa.3, ss.213-214, 2010 (SCI-Expanded)

20. Oral systemic administration of ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model

Bilgili H., Captug O., KOŞAR A., Kurt M., Kekilli M., Shorbagi A., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.16, sa.5, ss.533-536, 2010 (SCI-Expanded)

21. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd blood stopper

Haznedaroglu B. Z., HAZNEDAROĞLU İ. C., Walker S. L., Bilgili H., GÖKER H., KOŞAR A., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.16, sa.4, ss.446-453, 2010 (SCI-Expanded)

22. Hemostatic alterations in fatty liver disease

Kargili A., Cipil H., Karakurt F., Kasapoglu B., Koca C., Aydn M., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.21, sa.4, ss.325-327, 2010 (SCI-Expanded)

23. Effects of a topical hemostatic agent on an epistaxis model in rabbits

Kurtaran H., Ark N., Serife Ugur K., Sert H., Ozboduroglu A. A., KOŞAR A., et al.

Current Therapeutic Research - Clinical and Experimental , cilt.71, sa.2, ss.105-110, 2010 (SCI-Expanded)

24. In vivo hemostatic effect of the medicinal plant extract ankaferd blood stopper in rats pretreated with warfarin

Cipil H. S., KOŞAR A., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.15, sa.3, ss.270-276, 2009 (SCI-Expanded)

25. The efficacy of ankaferd blood stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model

KOŞAR A., Cipil H. S., Kaya A., Uz B., Haznedaroglu I. C., GÖKER H., et al.

Blood Coagulation and Fibrinolysis , cilt.20, sa.3, ss.185-190, 2009 (SCI-Expanded)

26. Hemostatic efficacy of ankaferd blood stopper® in a swine bleeding model

Bilgili H., KOŞAR A., Kurt M., Onal I. K., Goker H., Captug O., et al.

Medical Principles and Practice , cilt.18, sa.3, ss.165-169, 2009 (SCI-Expanded)

27. Venlafaxine-induced gynecomastia in a young patient: A case report

Karakurt F., Kargili A., Uz B., Kaya A., KOŞAR A., Ozkara A., et al.

Clinical Neuropharmacology , cilt.32, sa.1, ss.51-52, 2009 (SCI-Expanded)

28. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome

Karakurt F., Gumus I. I., Bavbek N., Kargili A., Koca C., Selcoki Y., et al.

Gynecological Endocrinology , cilt.24, sa.9, ss.491-497, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Responses of anterior pituitary hormones to fever during community-acquired infections

Alici Ö., Koca C., Kaya A., Karakurt F., Çarlioǧlu A., KOŞAR A., et al.

European Journal of General Medicine , cilt.5, sa.4, ss.216-221, 2008 (SCI-Expanded)

30. Hemostasis and global fibrinolytic capacity in chronic liver disease

Aytac S., Turkay C., Bavbek N., KOŞAR A.

Blood Coagulation and Fibrinolysis , cilt.18, sa.7, ss.623-626, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: Are they markers of vascular disease and diabetic nephropathy?

Bavbek N., Kargili A., Kaftan O., Karakurt F., KOŞAR A., Akcay A.

Clinical and Applied Thrombosis/Hemostasis , cilt.13, sa.4, ss.391-397, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Incidence and etiology of thrombocytosis in an adult Turkish population

Aydogan T., Kanbay M., Alici O., KOŞAR A.

Platelets , cilt.17, sa.5, ss.328-331, 2006 (SCI-Expanded)

33. Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis

Kaftan O., Balcik O., Cipil H., Ozet G., Bavbek N., KOŞAR A., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.11, sa.4, ss.449-454, 2005 (SCI-Expanded)

34. The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis

BİRDANE A., HAZNEDAROĞLU İ. C., Bavbek N., KOŞAR A., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.11, sa.2, ss.197-201, 2005 (SCI-Expanded)

35. Global fibrinolytic capacity increased exponentially in metastatic colorectal cancer

Kockar C., Kockar O., Ozturk M., Dagli M., Bavbek N., KOŞAR A.

Clinical and Applied Thrombosis/Hemostasis , cilt.11, sa.2, ss.227-230, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

36. A life-threatening second trimester disseminated intravascular coagulopathy with protein S deficiency

Seckin N. C., Inegöl I., Turhan N., Bavbek N., KOŞAR A.

Clinical and Applied Thrombosis/Hemostasis , cilt.10, sa.3, ss.289-291, 2004 (SCI-Expanded)

37. Eosinophilia in rheumatologic diseases: A prospective study of 1000 cases

Kargılı A., Bavbek N., Kaya A., KOŞAR A., Karaaslan Y.

Rheumatology International , cilt.24, sa.6, ss.321-324, 2004 (SCI-Expanded)

38. Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura

SAYINALP N., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., GÖKER H., AKSU S., Koçoǧlu H., et al.

Journal of International Medical Research , cilt.32, sa.1, ss.62-65, 2004 (SCI-Expanded)

39. Rheumatologic disease with peripheral eosinophilia

Bavbek N., Kargılı A., Cipil H., KOŞAR A., Karaaslan Y.

Rheumatology International , cilt.24, sa.6, ss.317-320, 2004 (SCI-Expanded)

40. Cardiac dysfunction in cirrhosis

Kaya D., Koçkar M. C., Bavbek N., Dagli M., KOŞAR A.

Hepatology Research , cilt.26, sa.3, ss.181-185, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Global fibrinolytic capacity in colorectal cancer: A new clue to occult fibrinolysis

Ozturk M., Sengul N., Dagli M., KOŞAR A., Bavbek N.

Clinical and Applied Thrombosis/Hemostasis , cilt.9, sa.2, ss.151-154, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Increased erythropoietin levels in reactive thrombocytosis

Balçik Ö. Ş., Öztürk M., Daǧli M., Kaftan O., KOŞAR A., Karaaslan Y., et al.

Haematologia , cilt.32, sa.1, ss.59-65, 2002 (SCI-Expanded)

43. Hemostatic parameters in Behçet's disease: A reappraisal

KOŞAR A., Öztürk M., HAZNEDAROĞLU İ. C., Karaaslan Y.

Rheumatology International , cilt.22, sa.1, ss.9-15, 2002 (SCI-Expanded)

44. Serum beta 2-microglobulin reflects disease activity in Behçet's disease

Aygündüz M., Bavbek N., Öztürk M., Kaftan O., KOŞAR A., Kirazli Å.

Rheumatology International , cilt.22, sa.1, ss.5-8, 2002 (SCI-Expanded)

45. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: Effects of different treatment modalities

Isler M., Delibas N., Guclu M., Gultekin F., Sutcu R., Bahceci M., et al.

Croatian Medical Journal , cilt.43, sa.1, ss.16-19, 2002 (SCI-Expanded)

46. Plasma thrombospondin in immune thrombocytopenic purpura

ÖZCEBE O. İ., Karakuş S., HAZNEDAROĞLU İ. C., GÖKER H., KOŞAR A., Koçoǧlu H., et al.

Journal of International Medical Research , cilt.30, sa.1, ss.52-55, 2002 (SCI-Expanded)

47. Thrombopoietin and mean platelet volume in coronary artery disease

Şenaran H., Ileri M., AltinbaŞ A., KOŞAR A., Yetkin E., ÖZTÜRK M., et al.

Clinical Cardiology , cilt.24, sa.5, ss.405-408, 2001 (SCI-Expanded)

48. Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis

Cobankara V., Oran B., Ozatli D., HAZNEDAROĞLU İ. C., KOŞAR A., BÜYÜKAŞIK Y., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.7, sa.2, ss.126-130, 2001 (SCI-Expanded)

49. Cardiac and great vessel thrombosis in Behçet's disease

Özatli D., KAV T., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., KOŞAR A., Özcebe O., et al.

Internal Medicine , cilt.40, sa.1, ss.68-72, 2001 (SCI-Expanded)

50. Hyperhomocysteinaemia and activated protein C resistance in Behcet's disease [1]

Altinbaş A., Aytemur K., Tokgözoǧlu L., ÖZTÜRK M., KOŞAR A., HAZNEDAROĞLU İ. C., et al.

Journal of Internal Medicine , cilt.248, sa.3, ss.267-268, 2000 (SCI-Expanded)

51. Selectin adhesion molecules in Behcet's disease

Haznedaroǧlu S., Karaaslan Y., BÜYÜKAŞIK Y., KOŞAR A., ÖZCEBE O. İ., Haznedaroǧ I. C., et al.

Annals of the Rheumatic Diseases , cilt.59, sa.1, ss.61-63, 2000 (SCI-Expanded)

52. Anemias in chronic liver diseases

Ozatli D., KÖKSAL A., HAZNEDAROĞLU İ. C., ŞİMŞEK H., Karakus S., BÜYÜKAŞIK Y., et al.

Hematology , cilt.5, sa.1, ss.69-76, 2000 (SCI-Expanded)

53. Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias

Özatli D., Koçǒglu H., HAZNEDAROĞLU İ. C., KOŞAR A., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

Haematologia , cilt.29, sa.4, ss.277-283, 1999 (SCI-Expanded)

54. Congenital dyserythropoietic anemia type II in a woman presenting with jaundice, anemia, and splenomegaly

Abali H., HAZNEDAROĞLU İ. C., SAYINALP N., KOŞAR A., BÜYÜKAŞIK Y., Ozatli D., et al.

Hematology , cilt.4, sa.4, ss.357-360, 1999 (SCI-Expanded)

55. Activity of factor VIIa and von Willebrand factor in non-insulin-dependent diabetic subjects with coronary artery disease

Altinbaş A., DOĞAN A., Özgüner F., KOŞAR A., Kirazli Ş.

Journal of International Medical Research , cilt.27, sa.4, ss.185-190, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

56. Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura

HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., KOŞAR A., ÖZCEBE O. İ., Kirazli Ş., Dündar S.

Acta Haematologica , cilt.101, sa.1, ss.16-20, 1999 (SCI-Expanded)

57. Thrombosis and hemorrhage in chronic myeloproliferative disorders [1]

Bas B., KÖKSAL A., Ozath D., HAZNEDAROĞLU İ. C., KOŞAR A., BÜYÜKAŞIK Y., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.5, sa.4, ss.282-284, 1999 (SCI-Expanded)

58. Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease

KOŞAR A., Haznedaroglu S., Karaaslan Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., Özath D., et al.

Rheumatology International , cilt.19, sa.1-2, ss.11-14, 1999 (SCI-Expanded)

59. Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmune versus aplastic thrombocytopenia

KOŞAR A., HAZNEDAROĞLU İ. C., Buyukasik Y., Ozcebe O., Kirazli S., Dundar S.

Haematologica , cilt.83, sa.11, ss.1055-1056, 1998 (SCI-Expanded)

60. Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura

HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., KOŞAR A., Kirazli Ş., Dündar S.

Annals of Hematology , cilt.77, sa.4, ss.165-170, 1998 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 9

1. The effect of lactose intolerance on plasma glucose levels and related biochemical parameters

YALÇIN K. S., KASAPOĞLU B., ALANLI R., KÜÇÜKAY M. B., YOZGAT A., KEKİLLİ M., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.4, ss.1110-1113, 2022 (Hakemli Dergi)

2. Quadruple of Bismuth, Pantoprazole, Amoxicillin and Metronidazole for the First-Line Helicobacter Pylori Eradication Therapy

YALÇIN K. S., KASAPOĞLU B., YOZGAT A., KOŞAR A.

Lokman Hekim Health Sciences , cilt.1, sa.2, ss.36-40, 2021 (Hakemli Dergi)

3. Mean Platelet Volume and Neutrophil/Lymphocyte Ratio among Patients with Ulcerative Colitis as an Indicator of Activation

YALÇIN K. S., KASAPOĞLU B., YOZGAT A., KOŞAR A.

Lokman Hekim Health Sciences , cilt.1, sa.1, ss.1-4, 2021 (Hakemli Dergi)

4. The Relationship between Vitamin D Levels and Body Mass Index and Fasting Blood Glucose in Non-Obese Non-Diabetic Women

YALÇIN K. S., KÜÇÜKAY M. B., KOŞAR A.

Lokman Hekim Health Sciences , cilt.1, sa.1, ss.5-8, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

5. spinning egzersizinin tetiklediği rabdomyoliz

TAHTACI G., ŞAHİN BALÇIK Ö., YALÇIN K. S., KOŞAR A.

ortadoğu tıp dergisi , cilt.6, sa.2, ss.106-107, 2014 (Hakemli Dergi)

6. Neutrophil-lymphocyte ratio may be superior to C-reactive protein for predicting the occurrence of postmenopausal osteoporosis

Yilmaz H., Uyfun M., Yilmaz T., Namuslu M., Inan O., Taskin A., et al.

Endocrine Regulations , cilt.48, sa.1, ss.25-33, 2014 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1198

H-İndeks (WoS)

Atıf (Scopus)

1367

H-İndeks (Scopus)

Atıf (Scholar)

3160

H-İndeks (Scholar)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler